
Thermo Fisher Scientific TMO
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
377 M |
Market Cap[1] |
$ 261 B |
EBITDA (LTM) |
$ 8.8 B |
P/E (LTM) |
34.540236 |
P/S (LTM) |
5.193354 |
EPS (LTM) |
17.77 |
Thermo Fisher Scientific is a globally leading company in the life science industry, focusing on the development and manufacturing of products and services for research, diagnostics, and drug production. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific offers a wide range of products, including laboratory equipment, reagents, consumables, software, and services. The company serves customers in the pharmaceutical and biotech, diagnostics, academic research, and government sectors.
The mission of Thermo Fisher Scientific is to help its customers make the world healthier, cleaner, and safer. The company is also committed to sustainability and aims to reduce its greenhouse gas emissions by 50% by 2030.
Thermo Fisher Scientific is known for its innovation and has received numerous awards for its products and technologies. The company has also made several acquisitions to expand its product offerings and strengthen its presence in different regions.
Overall, is a leading company in the life science industry that is committed to innovation, sustainability, and customer satisfaction. Its products and services have a positive impact on the health and well-being of people around the world.
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
DexCom
DXCM
|
$ 82.53 | 0.6 % | $ 32.2 B | Nasdaq Global Select Market,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Celcuity
CELC
|
$ 55.51 | -3.86 % | $ 2.6 B | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 9.02 | -1.04 % | $ 306 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Danaher Corporation
DHR
|
$ 228.43 | 1.18 % | $ 163 B | NYSE,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.72 | 1.87 % | $ 88.3 K | Nasdaq Capital Market | ||
|
Biodesix
BDSX
|
$ 8.42 | -5.18 % | $ 63.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 176.32 | 2.38 % | $ 50.1 B | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 0.98 | 3.13 % | $ 5.34 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 12.85 | 2.8 % | $ 135 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 10.64 | 0.38 % | $ 709 M | Nasdaq Global Select Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 259.18 | 1.1 % | $ 28.8 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 333.37 | 0.36 % | $ 16.5 B | NYSE,SPB | ||
|
Guardant Health
GH
|
$ 145.11 | 1.28 % | $ 18.2 B | Nasdaq Global Select Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 33.41 | 1.3 % | $ 968 M | Nasdaq Global Market,SPB | ||
|
Illumina
ILMN
|
$ 209.18 | 3.24 % | $ 32.4 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 257.93 | 0.13 % | $ 44.3 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 370.49 | 0.61 % | $ 30.8 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 700.79 | 1.53 % | $ 56.4 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 647.03 | -0.93 % | $ 18.7 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 734.36 | 1.25 % | $ 35.7 B | NYSE,SPB | ||
|
Natera
NTRA
|
$ 286.77 | -0.25 % | $ 39.2 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 102.03 | 0.23 % | $ 6.89 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 25.14 | 3.84 % | $ 774 M | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 74.4 | -0.21 % | $ 3.96 B | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Biomerica
BMRA
|
$ 1.15 | -6.88 % | $ 3.35 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 5.44 | -9.42 % | $ 24.1 M | Nasdaq Global Select Market | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 194.96 | -0.03 % | $ 15.3 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 9.76 | -3.99 % | $ 407 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 16.27 | 1.34 % | $ 4.62 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 0.2 | 1.99 % | $ 266 K | Nasdaq Capital Market | ||
|
Precipio
PRPO
|
$ 18.8 | -1.93 % | $ 30.2 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.